Article Information
History
- March 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Elliott D. SoRelle1,2,*,
- Ellora Haukenfrers3,
- Vaibhav Jain3,
- Karen Abramson3,
- Emily Hocke3,
- Laura A. Cooney5,6,
- Kristina M. Harris5,
- Scott S. Zamvil5,7,
- Simon G. Gregory1,3,8,*,^ and
- Micah A. Luftig1,*,^
- 1Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA
- 2Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA
- 3Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA
- 4Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA
- 5Immune Tolerance Network, Bethesda, MD 20814, USA
- 6Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor MI 48109, USA
- 7Department of Neurology, University of California at San Francisco, San Francisco, CA 94185, USA
- 8Department of Neurology, Duke University School of Medicine, Durham, NC 27710, USA
- ↵*Corresponding authors; email: micah.luftig{at}duke.edu
↵^ Equal contributors
Posted March 01, 2023.
An EBV-associated atypical B cell signature in clinically isolated syndrome is implicated in progression of multiple sclerosis
